Łażewska Dorota, Kaleta Maria, Schwed J Stephan, Karcz Tadeusz, Mogilski Szczepan, Latacz Gniewomir, Olejarz Agnieszka, Siwek Agata, Kubacka Monika, Lubelska Annamaria, Honkisz Ewelina, Handzlik Jadwiga, Filipek Barbara, Stark Holger, Kieć-Kononowicz Katarzyna
Department of Technology and Biotechnology of Drugs, Faculty of Pharmacy, Jagiellonian University Medical College, ul. Medyczna 9, 30-688 Kraków, Poland.
Department of Technology and Biotechnology of Drugs, Faculty of Pharmacy, Jagiellonian University Medical College, ul. Medyczna 9, 30-688 Kraków, Poland.
Bioorg Med Chem. 2017 Oct 15;25(20):5341-5354. doi: 10.1016/j.bmc.2017.07.058. Epub 2017 Jul 29.
Novel biphenyloxy-alkyl derivatives of piperidine and azepane were synthesized and evaluated for their binding properties at the human histamine H receptor. Two series of compounds were obtained with a meta- and a para-biphenyl moiety. The alkyl chain spacer contained five and six carbon atoms. The highest affinity among all compounds was shown by 1-(6-(3-phenylphenoxy)hexyl)azepane (13) with a K value of 18nM. Two para-biphenyl derivatives, 1-(5-(4-phenylphenoxy)pentyl)piperidine (14; K=25nM) and 1-(5-(4-phenylphenoxy)pentyl)azepane (16; K=34nM), classified as antagonists in a cAMP accumulation assay (IC=4 and 9nM, respectively), were studied in detail. Compounds 14 and 16 blocked RAMH-induced dipsogenia in rats (ED of 2.72mg/kg and 1.75mg/kg respectively), and showed high selectivity (hHR vs hHR>600-fold) and low toxicity (hERG inhibition: IC>1.70µM; hepatotoxicity IC>12.5µM; non-mutagenic up to 10µM). Furthermore, the metabolic stability was evaluated in vitro on human liver microsomes (HLMs) and/or rat liver microsomes (RLMs). Metabolites produced were analyzed and tentatively identified by UPLC-MS techniques. The results demonstrated easy hydroxylation of the biphenyl ring.
合成了新型哌啶和氮杂环庚烷联苯氧基烷基衍生物,并对其与人组胺H受体的结合特性进行了评估。获得了两个系列的化合物,分别带有间位和对位联苯部分。烷基链间隔基含有五个和六个碳原子。所有化合物中亲和力最高的是1-(6-(3-苯氧基)己基)氮杂环庚烷(13),其K值为18nM。详细研究了两种对位联苯衍生物,1-(5-(4-苯氧基)戊基)哌啶(14;K = 25nM)和1-(5-(4-苯氧基)戊基)氮杂环庚烷(16;K = 34nM),它们在cAMP积累试验中被归类为拮抗剂(IC分别为4和9nM)。化合物14和16可阻断大鼠中RAMH诱导的烦渴(ED分别为2.72mg/kg和1.75mg/kg),并表现出高选择性(hHR1与hHR2>600倍)和低毒性(hERG抑制:IC>1.70µM;肝毒性IC>12.5µM;高达10µM时无致突变性)。此外,在人肝微粒体(HLMs)和/或大鼠肝微粒体(RLMs)上体外评估了代谢稳定性。通过超高效液相色谱-质谱技术分析并初步鉴定了产生的代谢物。结果表明联苯环易于羟基化。